Biotech Startups

0 investors

0 investors

0 investors

0 investors

0 investors

0 investors

Perspective Therapeutics is a radiopharmaceutical company developing image-guided, targeted alpha-particle therapies for cancer, using Pb-212-based radiotherapies delivered to tumor cells via high-affinity targeting peptides. It runs a clinical-stage pipeline of theranostic programs for indications including neuroendocrine tumors, melanoma, and other solid tumors.

0 investors

iSpecimen operates an online marketplace that connects medical researchers to a global network of biospecimen providers, offering access to human biospecimens such as diagnostic remnant, banked, and prospective collections. The platform serves the biospecimen procurement needs of researchers in the life sciences and healthcare research industry.

0 investors

The page presents team members affiliated with Cambrian Bio, describing roles in R&D project management, business operations, and medicinal chemistry consulting within drug discovery and development. The individuals have backgrounds in developing medicines and small-molecule therapeutics across pharma and biotech.

0 investors

iVeena Delivery Systems is a clinical-stage ophthalmology company developing pharmacologic eye-drop therapies for refractive eye diseases, including IVMED-80 for keratoconus and IVMED-85 for pediatric myopia. Its lead keratoconus asset has been licensed to Glaukos Corporation.

0 investors

Ixcela operates a virtual Registered Dietitian clinic focused on gut health, using a proprietary at-home gut health test and an AI-based digital evaluation tool to create personalized dietary recommendations. It offers supportive care for patients dealing with cancer symptoms, weight/metabolic issues, and other health challenges, and accepts major commercial insurance for dietitian visits.

0 investors

0 investors

0 investors

J3 Bio develops an FDA-cleared intravaginal ring platform called LivRing for delivering active and functional ingredients to address women's health needs across multiple conditions and life stages. The company targets the direct-to-consumer women's health market with clinically validated solutions designed for accessibility outside traditional medical channels.

0 investors

Jabez Biosciences is a clinical-stage biotechnology company developing oral small-molecule cancer therapeutics under a "3-S" (seamless, scalable, synergistic) framework designed to combine with standard treatments. Its lead compound, JBZ-001, is an oral DHODH inhibitor in a Phase 1 trial for advanced solid tumors and non-Hodgkin lymphoma.

0 investors

0 investors

Jaguar Health is a pharmaceutical company developing crofelemer, including a novel powder for oral solution formulation, for gastrointestinal conditions and rare intestinal failure indications such as microvillus inclusion disease (MVID) and short bowel syndrome with intestinal failure (SBS-IF) in adults and children. It works through its family companies Napo Pharmaceuticals and Napo Therapeutics.

0 investors

JangoBio is a biotechnology company developing regenerative stem cell therapies aimed at aging and age-related diseases by restoring sex hormone balance. It builds cell-based organoids designed to regenerate or replace gonadal tissues lost during aging to increase hormone production and longevity.

0 investors

0 investors

0 investors

0 investors

jCyte is a clinical-stage biotechnology company developing jCell, an investigational cell-based therapy for retinitis pigmentosa and other inherited retinal and blinding diseases. It is advancing multiple drug development programs targeting degenerative retinal disorders and optic nerve conditions to preserve and restore vision.

0 investors

0 investors

0 investors